Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine
Akira Hata1, Yoshihiro Onouchi
1Department of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan. ahata@faculty.chiba-u.jp
Insights
Kawasaki disease (KD) is a vasculitis affecting young children. Genetic studies identified inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) as a predisposing gene, paving the way for personalized medicine.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Genetics
Background:
- Kawasaki disease (KD) is an acute systemic vasculitis primarily affecting children under five.
- Untreated KD leads to coronary artery lesions in 20-25% of cases, a leading cause of acquired heart disease in children.
- Extensive epidemiological data from Japan since 1970 reveal a strong genetic influence on KD susceptibility.
Purpose of the Study:
- To review cumulative knowledge on Kawasaki disease.
- To outline a hypothesis on the role of ITPKC in KD susceptibility.
- To describe efforts toward personalized medicine for KD.
Main Methods:
- Genome-wide linkage study using affected sibling pair data from Japan.
- Analysis of susceptibility loci, focusing on chromosome 19.
- Identification of the predisposing gene, inositol 1,4,5-trisphosphate 3-kinase C (ITPKC).
Main Results:
- Identification of several susceptibility loci for Kawasaki disease.
- Pinpointing ITPKC as a predisposing gene for KD.
- Establishing a genetic basis for KD susceptibility.
Conclusions:
- ITPKC plays a significant role in Kawasaki disease susceptibility.
- Understanding the genetic underpinnings of KD is crucial for developing targeted therapies.
- Research is progressing towards personalized medicine approaches for Kawasaki disease management.
Abstract:
Kawasaki disease (KD) is an acute systemic vasculitis syndrome, which primarily affects in children under the age of 5 years. In 20-25% of cases, if untreated, coronary artery lesions develop, making KD the leading cause of acquired heart disease in children in both Japan and the United States. Since 1970, 19 nationwide surveys of KD in Japan have been conducted every 2 years and the data are stored in a database. Even though the etiology of KD remains unknown, despite enthusiastic research spanning more than 40 years, we have learnt a great deal about KD from this enormous database. These 19 epidemiologic studies indicate a strong genetic influence on the disease susceptibility, prompting us and other researchers to identify the responsible genes for KD by applying either the candidate gene approach or the genome-wide approach. We have employed a genome-wide linkage study using affected sibling pair data of KD in Japan and have identified several susceptibility loci. Further analysis focusing on a region of chromosome 19, where one of the linked loci was detected, identified a predisposing gene, which codes inositol 1,4,5-trisphosphate 3-kinase C (ITPKC). In this review, we summarize the cumulative knowledge regarding KD, and then outline our hypothesis of the role ITPKC plays in KD susceptibility and our trial that aims toward the implementation of personalized medicine for KD.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics and Pharmacogenomics: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
